Neurovance raises another $5.5M for abuse-resistant ADHD drug
Boston Business Journal (blog)
In December, the company said initial trials in a 2a patient study show the drug is effective and deters abuse better than currently approved drugs for ADHD, because higher doses of the drug causes negative side-effects before the positive effects of ...
Thursday, March 26, 2015
Collaborative Care Enhances ADHD Treatment for Children
A recent study published in the journal Pediatrics found that a “collaborative care” model, which uses a “care manager” as a liaison between parents and pediatricians, was more effective at treating ADHD in children than a standard pediatrician ...
Craniosacral Therapy: A Natural Treatment for ADHD
“There was one guy I knew,” the doctor told me as she pressed her fingers into my skull, “who was having so much success helping kids with ADHD that the Ritalin people smeared his business and he had to fight to keep his license.” Which, if it is true ...
One-sixth of College Students Misuse ADHD Stimulants
Mad In America
About 17% of college students take stimulants such as Ritalin and Adderall, primarily because they believe the drugs will help them improve their academic performance, according to a meta-analysis published in Clinical Child and Family Psychology Review.
Can A Family-Centered Approach Be The Best Treatment for ADHD Patients?
There has been much study on ADHD lately. Understanding the neuro-chemical foundations of this condition will help us to determine what can help treat it and possibly even prevent it. In many cases, diet and lifestyle, for example, could be of great ...
Tuesday, March 24, 2015
Telehealth: Treatment for ADHD using Videoconferencing
If you live outside of a major metropolitan area, you know that finding local ADHD specialists is seldom easy. But now parents can confidently look beyond their geographic region for psychiatrists, therapists, and behavior-therapy consultants who offer ...
New ADHD Drug Dosing Option Now Available
Pharmacy Times (registration)
Shire's ADHD treatment, lisdexamfetamine dimesylate (Vyvanse), is now available in a 10-mg titration dose at US pharmacies. The FDA approved this seventh capsule strength of Vyvanse for ADHD patients aged 6 years and older in October 2014.